What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cardiology
- Heart failure
The scientist’s investigation covers issues in Internal medicine, Cardiology, Hypertrophic cardiomyopathy, Cardiomyopathy and Heart disease.
His Internal medicine study integrates concerns from other disciplines, such as Surgery and Cardiothoracic surgery.
His work deals with themes such as Blood pressure and Diastole, which intersect with Cardiology.
Steve R. Ommen has researched Hypertrophic cardiomyopathy in several fields, including Genetics, Guideline, Pathology, Family history and TNNT2.
His work carried out in the field of Cardiomyopathy brings together such families of science as Titin, Telethonin, Sudden death, Mitral valve and Genetic testing.
His Heart disease study incorporates themes from Coronary artery disease, Lymphocyte, Proportional hazards model and Transplantation.
His most cited work include:
- Clinical Utility of Doppler Echocardiography and Tissue Doppler Imaging in the Estimation of Left Ventricular Filling Pressures A Comparative Simultaneous Doppler-Catheterization Study (2431 citations)
- 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines (1595 citations)
- 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoraci (929 citations)
What are the main themes of his work throughout his whole career to date?
Steve R. Ommen mainly focuses on Internal medicine, Hypertrophic cardiomyopathy, Cardiology, Cardiomyopathy and Septal myectomy.
Steve R. Ommen regularly links together related areas like Surgery in his Internal medicine studies.
His studies deal with areas such as Left ventricular hypertrophy, Sudden death, Implantable cardioverter-defibrillator, Pathology and Sudden cardiac death as well as Hypertrophic cardiomyopathy.
His study brings together the fields of Diastole and Cardiology.
His research brings together the fields of Muscle hypertrophy and Cardiomyopathy.
His Septal myectomy research incorporates elements of Obstructive hypertrophic cardiomyopathy, Mitral valve, Concomitant, Heart septum and Mitral regurgitation.
He most often published in these fields:
- Internal medicine (80.54%)
- Hypertrophic cardiomyopathy (75.68%)
- Cardiology (75.41%)
What were the highlights of his more recent work (between 2018-2021)?
- Hypertrophic cardiomyopathy (75.68%)
- Internal medicine (80.54%)
- Cardiology (75.41%)
In recent papers he was focusing on the following fields of study:
Steve R. Ommen mainly investigates Hypertrophic cardiomyopathy, Internal medicine, Cardiology, Septal myectomy and Sudden cardiac death.
The concepts of his Hypertrophic cardiomyopathy study are interwoven with issues in Aortic valve replacement, Implantable cardioverter-defibrillator, Guideline, Cardiomyopathy and Atrial fibrillation.
His research in Cardiology intersects with topics in Interquartile range and Hazard ratio.
His Septal myectomy research is multidisciplinary, incorporating perspectives in Ventricular outflow tract, Concomitant, Surgery, Mitral valve and Coronary artery disease.
His studies deal with areas such as Subaortic stenosis and Heart disease as well as Ventricular outflow tract.
The study incorporates disciplines such as Automatic summarization, Cardiac magnetic resonance imaging, High sensitivity troponin and Family history in addition to Sudden cardiac death.
Between 2018 and 2021, his most popular works were:
- Detection of Hypertrophic Cardiomyopathy Using a Convolutional Neural Network-Enabled Electrocardiogram (30 citations)
- Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy: A propensity score–matched cohort (27 citations)
- 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines (24 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cardiology
- Surgery
Hypertrophic cardiomyopathy, Internal medicine, Cardiology, Septal myectomy and Sudden cardiac death are his primary areas of study.
His Hypertrophic cardiomyopathy study combines topics from a wide range of disciplines, such as Guideline, Cardiomyopathy, Andrology, Univariate analysis and Family history.
Steve R. Ommen carries out multidisciplinary research, doing studies in Internal medicine and Risk assessment.
His Cardiology research incorporates elements of Interquartile range and Hazard ratio.
His Septal myectomy study also includes fields such as
- Mitral valve that intertwine with fields like Concomitant and Mitral regurgitation,
- Ventricular outflow tract obstruction which connect with Ventricular outflow tract, Alcohol septal ablation and Etiology.
His research integrates issues of Patient survey, Left ventricular hypertrophy, Health records and Automatic summarization in his study of Sudden cardiac death.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
